Jun Ding

Heterologous boost with mRNA vaccines against SARS-CoV-2 Delta/Omicron variants following an inactivated whole-virus vaccine

Fei Liu, W. Jia, Xiaoming Yang, 2022, bioRxiv.

Pre-Existing HSV-1 Immunity Enhances Anticancer Efficacy of a Novel Immune-Stimulating Oncolytic Virus

I. Samudio, W. Jia, I-Fang Lee, 2022, Viruses.

Targeting carcinoembryonic antigen-expressing tumors using a novel transcriptional and translational dual-regulated oncolytic herpes simplex virus type 1

I. Samudio, X. Bu, Guoyu Liu, 2023, Molecular therapy oncolytics.

Combination of novel oncolytic herpesvirus with paclitaxel as an efficient strategy for breast cancer therapy

Chenfang Dong, Qiao-yun Leng, Chaomei Zhang, 2023, Journal of medical virology.

HSV-1 Oncolytic Virus Targeting CEACAM6-Expressing Tumors Using a Bispecific T-Cell Engager

W. Jia, H. van Faassen, Guoyu Liu, 2023, bioRxiv.

Novel mRNA vaccines encoding Monkeypox virus M1R and A35R protect mice from a lethal virus challenge

W. Jia, Yingying Song, Xiaoming Yang, 2022, bioRxiv.

Prophylactic Vaccination and Intratumoral Boost with HER2-Expressing Oncolytic Herpes Simplex Virus Induces Robust and Persistent Immune Response against HER2-Positive Tumor Cells

Guoyu Liu, Y. Murad, Xiaohu Liu, 2023, Vaccines.